Discover 1 curated intelligence briefings related to this specific topic.
While the West treats GLP-1s as a bridal fad or a dosing risk, Southeast Asia is integrating these metabolic tools into a broader, regulated longevity ecosystem that blends biotechnology with preventative healthcare.
